Razmik Abnous

Co-founder at DiscoverA; Co-founder at Confidencial Inc.; ex CTO of Documentum

📍 San Francisco Bay Area, United States🔄 Updated September 2026💼 3 investments📅 27 years investing🗓 Last invested Jan 2001𝕏 @upgrade_to_unlock
VC🌍 United States
3
Total investments
1
Early stage
0
Mid stage
0
Late stage
27y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Advisor
Jan 2001
Integrien Corporation is the real-time performance analytics company that enables the predictable operation of mission critical applications and services. Integrien helps IT to manage complexity by applying real-time analytics to monitoring data to provide the intelligence that prevents problems from negatively impacting business. Its flagship product, Integrien Alive™ allows IT to take a proactive approach to performance management, telling them when an application problem is brewing with a single Smart Alert™ that isolates the impact and likely root cause. The company was founded in 2002 and is headquartered in Irvine, California.”
Investor
May 2000
e2020 Technology offers cloud based Solution as a Service (SaaS). We provide customized information systems for project management. Each of our Project Management Information System (PMIS) is turn-key solution customized to suit the workflow and specific functional needs of various levels of the project team. It serves as one-stop information center for efficient project control, orderly managed documentation, and a friendly hub streamlined to enable effective project execution. The e2020 PMIS modules seamlessly integrate with GIS Maps, BIM and Schedules. Its long history of field success covers public and private sectors projects. e2020 has deployed solutions for the following engineering markets: * Design-Build Engineering Management System * Construction Management System * Environmental Permit & Compliance Management System * General Project Management System
Investor and Advisor
Dec 1999
Emerging technology company engaged in research and development, and engineering services.
Experience · 10 entries
All (10)
Investments (3)
Founder (6)
2023
Co-founder and Chief AI Executive Officer
Jan 2023
DiscoverA is the only AI-native audit platform purpose-built for regulated environments, dramatically reducing audit cycle times, while significantly lowering compliance risk and manual evidence collection.
2021
CEO and Co-founder
Apr 2021
Confidencial is a Menlo Park, California-based provider of privacy enhancing technologies for securing sensitive information and collaboration for modern distributed enterprises. Its core technology, which integrates with existing business applications, was originally developed under Defense Advanced Research Projects Agency (DARPA) programs. Its founding team is composed of leading business software executives and cybersecurity and cryptography experts. For more information, please visit www.confidencial.io.
2015
EIR
Oct 2015
GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software and analytics, advanced manufacturing, energy and healthcare, GE Ventures helps entrepreneurs and start-ups succeed by providing access to GE's technical expertise, capital and opportunities for commercialization through GE's global network of business, customers and partners. For more information, please visit ge.com/ventures or contact us at connect.geventures@ge.com.
Co Founder and Advisor
Jan 2015
The proven software platform for cell and gene therapy supply chain management. From the beginning, Vineti’s founders have understood the challenges that biotech and pharmaceutical innovators face in developing personalized therapies. Vineti’s Personalized Therapy Management (PTM®) platform is the essential enterprise software to drive and scale global personalized therapies, such as cell therapies, gene therapies, and cancer vaccines. PTM® connects the right patient to the right product, on time and on track.
Co Founder and Advisor
Jan 2015
The proven software platform for cell and gene therapy supply chain management. From the beginning, Vineti’s founders have understood the challenges that biotech and pharmaceutical innovators face in developing personalized therapies. Vineti’s Personalized Therapy Management (PTM®) platform is the essential enterprise software to drive and scale global personalized therapies, such as cell therapies, gene therapies, and cancer vaccines. PTM® connects the right patient to the right product, on time and on track.
Show all 10 entries ↓
Investment activity
1999–2001 · 3 investments
199912000120011
Recent (last 2 years)Earlier